125 related articles for article (PubMed ID: 15230722)
1. p27 and Barrett's esophagus: a review*.
Ellis FH; Loda M
Dis Esophagus; 2004; 17(2):113-7. PubMed ID: 15230722
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
[TBL] [Abstract][Full Text] [Related]
4. [Molecular events associated with Barrett's oesophagus].
Nakajima H; Omura K
Nihon Rinsho; 2005 Aug; 63(8):1362-5. PubMed ID: 16101222
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
6. [Carcinogenesis of Barrett's esophagus].
Endo T; Sugawara N; Shinomura Y
Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus.
Wilson KT
Dis Esophagus; 2002; 15(1):16-21. PubMed ID: 12060038
[TBL] [Abstract][Full Text] [Related]
9. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
[TBL] [Abstract][Full Text] [Related]
10. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice.
Ellis FH; Xu X; Kulke MH; LoCicero J; Loda M
J Thorac Cardiovasc Surg; 2001 Oct; 122(4):809-14. PubMed ID: 11581618
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus: cancer and molecular biology.
Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.
Lord RV; Danenberg KD; Danenberg PV
Am J Gastroenterol; 1999 Aug; 94(8):2313-5. PubMed ID: 10445576
[No Abstract] [Full Text] [Related]
16. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite analysis provides evidence of neoplastic transformation in long-segment, but not in short-segment, Barrett's oesophagus.
Gleeson CM; McDougall NI; Russell SE; McGuigan JA; Collins JS; Sloan JM
Int J Cancer; 2000 Feb; 85(4):482-5. PubMed ID: 10699918
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.
Fitzgerald RC
Gut; 2006 Dec; 55(12):1810-20. PubMed ID: 17124160
[No Abstract] [Full Text] [Related]
19. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
20. Early Barrett's carcinoma of the esophagus.
Hölscher AH; Vallböhmer D; Bollschweiler E
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
